About Event
This two-day virtual conference focuses on translational aspects of addiction research among chemists, biologists, and behavioral scientists. The diversity of participants and attendees at this meeting (undergraduate students to senior faculty, chemists to psychiatrists) provides a unique venue for networking among different disciplines and in so doing promotes new and innovative approaches to medications development in addictions biology. The meeting provides a stimulating environment for young scientists who are strongly encouraged to present their work and interact with senior scientists. The BBC meeting has served as a “launch pad” for many young, innovative investigators to join the ever-growing world of SUD research.
2017 Featured Speakers
Sam QuinonesTopic: Dreamland: America's opiate-addiction epidemic and how we got where we are today |
 Jack Bergman, PhDTopic: Contextual factors in the reinforcing effects of drugs |
 Christopher McCurdy, PhDTopic: Development and clinical translation of sigma receptor ligands as diagnostics and therapeutics for pain |
Plenary Symposium
The opioid epidemic: history, formulations, regulations, and emergencies
The abuse of prescription and illicit opioids is at epidemic proportions, resulting in a public health crisis. Tackling such a complex issue will require interdisciplinary approaches involving basic science, engineering science, epidemiology, regulatory guidance, and patient and healthcare worker education. The symposium will focus on four such interrelated areas, specifically the history of how the epidemic grew, approaches to reducing diversion using formulation, the science behind the development of federal regulations, and a discussion of the optimal pharmacological profile required for new opioids to prevent abuse. The goal is the education of all attendees in the numerous interconnected factors that require solving as society moves to eliminate the opioid abuse epidemic.
Symposium Speakers
 |
Lewis S Nelson, PhDRutgers University, New Jersey Medical School |
From opiophobia to abuse deterrent formulations: the making of an opioid epidemic. |
 |
Mansoor Khan, PhDTexas A&M University |
Abuse deterrent formulations: design strategies and evaluation |
 |
Silvia N Calderon, PhDUS Food & Drug Administration |
Prescription opioids: abuse potential, scheduling and the current opioid epidemic |
 |
Andrew Coop, PhDUniversity of Maryland School of Pharmacy |
Beyond formulations: solving the opioid epidemic with new chemical entities |